Idaho Bladder Cancer Resources – Bladder Cancer Advocacy Network

English Español

Donate

Return to Map

Idaho Department of Health and Welfare
http://healthandwelfare.idaho.gov/

Contact Your State Elected Representative

https://legislature.idaho.gov/legislators/whosmylegislator/

Bladder Cancer Cases in Idaho at a Glance

540

New State Cases
82,290

New National
Cases
62,420

National Cases in Men
19,870

National Cases in Women
16,710

National Deaths

Veterans Administration Hospitals

Boise VA Medical Center

Bladder Cancer Clinical Trials in Idaho

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC) Disitamab Vedotin in Subjects With HER2 Expressing Urothelial Carcinoma

See more clinical trials